follow us on...

Loyola University releases statement that senior MF Layne (Malvern Prep) will play with testicular mass

Friday, 10th May 2013

Categories Boy's/Men's, College, NCAA Philly Final Four, Posted 5/10/13
From Press Releases

The Loyola University athletic department – through the Layne family – released a statement today that senior midfielder and Malvern Prep graduate Chris Layne was recently diagnosed with a testicular mass and will undergo further treatment, but will delay his treatment until after the NCAA Division I tournament.

Layne – a high school All-American and pick in 2008 – is Loyola’s fourth-leading scorer with 14 goals and nine assists and has been a regular since transferring from North Carolina last year, when he helped the Greyhounds win their first NCAA championship.Chris Layne

Loyola travels to Duke for a first-round game Sunday (5 p.m.) in the tournament.

Statement from the family of Loyola University Maryland senior midfielder Chris Layne:

“Earlier this week, Chris was diagnosed with a testicular mass that will require further medical treatment. In consultation with doctors, Chris has decided to complete his collegiate lacrosse career where he loves to be, on the field with the teammates with whom he has a tremendous bond.

“We have been part of the Loyola lacrosse family for many years, and the support we have received has been tremendous. We would like to thank Coach Toomey and his staff, Chris’ teammates and their families for their comfort during this time. We believe that there is no better place for our family to be at this time because of their care for Chris and our family.”

Statement from Loyola Coach Charley Toomey

“Throughout the last several days, our thoughts have been on the health and long-term well-being of Chris Layne. We are looking forward to Chris being with us in the playoffs, and he and his family will remain in our thoughts and prayers as he prepares for a new, post-playoffs battle.”


Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.

Latest Headlines